BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10863885)

  • 1. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
    Black K; Shea C; Dursun S; Kutcher S
    J Psychiatry Neurosci; 2000 May; 25(3):255-61. PubMed ID: 10863885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
    Schatzberg AF; Haddad P; Kaplan EM; Lejoyeux M; Rosenbaum JF; Young AH; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():5-10. PubMed ID: 9219487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delirium following abrupt discontinuation of fluoxetine.
    Blum D; Maldonado J; Meyer E; Lansberg M
    Clin Neurol Neurosurg; 2008 Jan; 110(1):69-70. PubMed ID: 17913343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible explanation for dizziness following SSRI discontinuation.
    Smith PF; Darlington CL
    Acta Otolaryngol; 2010 Sep; 130(9):981-3. PubMed ID: 20144124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of antidepressant discontinuation.
    Rosenbaum JF; Zajecka J
    J Clin Psychiatry; 1997; 58 Suppl 7():37-40. PubMed ID: 9219493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SSRI discontinuation syndrome.
    Haddad P
    J Psychopharmacol; 1998; 12(3):305-13. PubMed ID: 10958258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(3):169-75. PubMed ID: 20066803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.
    van Geffen EC; Hugtenburg JG; Heerdink ER; van Hulten RP; Egberts AC
    Eur J Clin Pharmacol; 2005 Jun; 61(4):303-7. PubMed ID: 15906018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
    Edwards JG; Anderson I
    Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delirium Associated With Fluoxetine Discontinuation: A Case Report.
    Fan KY; Liu HC
    Clin Neuropharmacol; 2017; 40(3):152-153. PubMed ID: 28452902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSRI withdrawal syndrome in children and adolescents: a narrative literature review.
    Khan YS; Khoodoruth MAS; Albobali Y; Haddad PM
    Expert Opin Drug Saf; 2023; 22(5):381-390. PubMed ID: 37339264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.